Group 1 - A new company, Tianjin Yimai Yingrun Medical Imaging Diagnosis Co., Ltd., has been established with a registered capital of 20 million RMB [1] - The legal representative of the company is Ma Zhi Hua, and it is located in the Tianjin Beichen Economic and Technological Development Zone [1] - The company is primarily involved in medical services, medical equipment leasing, and health management services [1] Group 2 - Shareholding structure includes Guangdong Hengqin Yimai Sunshine Medical Management Co., Ltd. (40%), Jiangxi Yimai Sunshine Group Co., Ltd. (30%), Zhao Li (20%), and Jiangxi Quandong Technology Co., Ltd. (10%) [1] - The company operates in the pharmaceutical manufacturing industry, specifically in the chemical drug preparation manufacturing sector [1] - The business scope includes various medical equipment leasing and sales, as well as technology services and consulting [1]

Summary of Key Points Core Viewpoint - Guoke Hengtai (Beijing) Medical Technology Co., Ltd. plans to provide a total guarantee amount of 1.855 billion yuan to its subsidiaries within the next twelve months, with a significant portion allocated to subsidiaries with an asset-liability ratio exceeding 70% [1]. Group 1: Guarantee Overview - The total guarantee amount planned is 1.855 billion yuan, with 1.415 billion yuan designated for subsidiaries with an asset-liability ratio above 70% and 440 million yuan for those below 70% [1]. - The guarantees will be controlled based on the actual effective amounts, and subsidiaries can adjust their guarantee limits within the total amount [1]. - Guarantees exceeding 1.225 billion yuan will require board approval, while those below this threshold can be approved by the general manager's office [1]. Group 2: Risk Management - For guarantees exceeding the company's shareholding ratio, the other shareholders of the guaranteed subsidiaries must provide sufficient and realizable counter-guarantees valued at no less than 1.3 times the amount exceeding the company's shareholding [1]. - If effective counter-guarantees cannot be provided, the company may charge corresponding guarantee fees to mitigate compensation risks [1]. - The guarantee fee rate is set at 1.00% per year for amounts corresponding to the company's shareholding and 2.50% per year for amounts exceeding the shareholding [1]. Group 3: Subsidiary Information - The subsidiaries involved in the guarantee include Guoke Hengxiang (Tianjin) Medical Technology Co., Ltd., Guoke Hengkai (Shanghai) Medical Technology Co., Ltd., and others, with varying asset-liability ratios and ownership structures [4][6]. - The most recent financial data indicates that the asset-liability ratio for the subsidiaries is approximately 75.15% as of March 31, 2025 [4].